# Dapsone

NDC: 64980-567
Generic name: dapsone
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230720

FDA application: ANDA207165

## Active ingredients

- DAPSONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64980-567"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64980-567
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e369b26d-219a-4e23-b8d4-f94048d36acd